Home  >  Products  >  Gapdh (glyceraldehyde-3-phosphate dehydrogenase ) Blocking Peptide (the C terminal of Gapdh)(100ug)
Gapdh (glyceraldehyde-3-phosphate dehydrogenase ) Blocking Peptide (the C terminal of Gapdh)(100ug)

Gapdh (glyceraldehyde-3-phosphate dehydrogenase ) Blocking Peptide (the C terminal of Gapdh)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Gapdh Antibody (ARP40188_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP40188
Size: 100ug
Weight: 36kDa
Gene: 14433
Format: Lyophilized powder
Target: Gapdh has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate. Gapdh also participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC.
Alternative names: Gapd; MGC102544; MGC102546; MGC103190; MGC103191; MGC105239
See Full Product Listings >